Repos Pharma Overview
- Founded
- 2013
- Status
- Private
- Latest Deal Type
- Early Stage VC
- Investors
- 1
Repos Pharma General Information
Description
Operator of a drug research and development company designed to provide treatment for cancer. The company's platform provides re-profiling drugs for treating additional forms of cancer, enabling cancer patients to begin their treatment and get a successful treatment for cancer.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- Bredgrand 14
- 753 20 Uppsala
- Sweden
Repos Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | Completed | Startup |
Repos Pharma Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Sven Mårten Fryknäs | Co-Founder & Chief Executive Officer |
Repos Pharma Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Angelica Loskog | Nxt2b | Chairman | 000 0000 |
Repos Pharma Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Nxt2b | Venture Capital | Minority | 000 0000 | 000000 0 |